Proceedings of the National Academy of Sciences · 2006 · 126 citations · 41 references
Life SciencesBiochemistryMolecular BiologyCell SignalingInnate ImmunitySignal TransductionAntiviral ImmunityInnate Immune Signaling PathwaysLigand BindingProtein Interaction DomainsProtein-ligand BindingRna-protein InteractionsActivating Point MutationsAntiviral Innate Immune SignalingAntiviral Innate SignalingAntiviral Signaling PathwaysPoint MutationsProtein Binding MotifRna-binding Domain StructureRna-binding Motif
The mammalian protein kinase PKR is a critical component of the innate immune response against virus infection. Its cellular actions are mediated by modulating cell signaling and translational regulation. To be enzymatically active, latent PKR needs to be activated by binding to one of its activators, dsRNA or PACT protein. Although the structures of the N-terminal dsRNA-binding domain and the C-terminal kinase domain of PKR have been separately determined, the mode of activation of the enzyme remains unknown. To address this problem, we used biochemical, genetic, and NMR analyses to identify the PACT-binding motif (PBM) located in the kinase domain and demonstrated an intramolecular interaction between PBM and dsRNA-binding domain. This interaction is responsible for keeping PKR in an inactive conformation, because its disruption by point mutations of appropriate residues produced constitutively active PKR. Furthermore, a short decoy peptide, representing PBM, was able to activate PKR by interfering with the intramolecular interaction. These observations suggest a model for PKR activation upon binding of dsRNA or PACT.
41
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers
Sandra S. Diebold, María Montoya, Hermann Unger et al. · Nature · 2003 · 574 citations